Genstar Capital acquires Bracket
Middle-market private equity firm Genstar Capital has acquired Bracket, a scientifically-driven clinical trial technology and specialty services provider, from Parthenon Capital Partners. Bracket offers solutions that help pharmaceutical and biotechnology companies, as well as contract research organisations, maximise clinical data integrity and ultimately improve outcomes with clinical trials. Bracket




